Buy medications

Treatment Of Bulimia Nervosa

Cognitive-behavioral therapy was considered to be the gold standard in the treatment of bulimia and binge eating disorder. In 1993, Stuart Agras, a prominent researcher from Stanford University, investigated the current treatment of binge eating, posing two complex questions. Agras emphasized the importance of learning which factors maintain binge eating and in which way a specific therapy influenced these factors.

He discussed the variation in assessment methods that made comparisons between and across studies extremely difficult. He found that studies differed in diagnostic criteria, outcome criteria, and length of follow-up intervals. Never take Xenical if you have bulimia nervosa. Researchers performed a 2- to 9-year follow-up study on 52 women with the diagnosis of bulimia nervosa according to the DSM-III-R. The patients were treated in an inpatient eating disorders unit at a university hospital, using behavioral methods to address eating behaviors, individual psychotherapy, pharmacotherapy group therapy, and family therapy. Of the 52 women, 46 women were interviewed, 1 had died, and 5 could not be located.

Of the 46 inpatient bulimic women, 39% had fully recovered and 41% were still symptomatic. The longer period of time after discharge, the greater percentage of patients recovered. At the end of year one, 15% had recovered versus 67% at the end of year 8. This course is now also available online and it can help you get out of an eating disorder for good. Another group in 1999 found the same results as the previous group in that the number of women who were symptomatic for bulimia nervosa declined as the length of time post-treatment increases.

Researchers strictly defined eating disorder outcome with both narrow and broad definitions. The narrow definition required a subject to be free of bulimic symptomotology for a period of six months, and in addition, for the subject not to use body weight and shape as a way of judging herself. Women who had not met criteria for full remission but who no longer met DSM-IV criteria were considered to be in partial remission. The researchers had a group of 173 women, with a mean duration of follow-up of 11.5 +/- 1.9 years.